Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 26, 2024
Abstract
In
this
study,
new
tetrahydrosoquinoline
compounds
were
synthesized
by
reacted
with
methyl
iodide,
chloro
acetonitrile,
ethyl
chloroacetate,
N-arylchloroacetamides
N-and
(benzthiazol-2-yl)-2-chloroacetamide
reagents
to
gave
tetrahydroiso-quinolin-3-ylthio)
acetamides
(5a-c)
which
can
cyclized
(6a-c)
in
excellent
yields.
The
structures
of
all
newly
characterized
elemental
and
spectral
analyses.
Also,
most
the
evaluated
for
their
anticancer
activity
MCF7HEPG2
cell
lines.
From
result
we
found
that
potent
compound
against
lines
was
9b,
active
3.
Then
effects
3
on
HEPG2
line
investigated
using
an
apoptotic
Annexin
V-FITC
test
flow
cytometry.
Compound
induced
a
59-fold
increase
apoptosis
cycle
arrested
at
G0-G1,
G2/M
phases.
Moreover,
molecular
docking
study
applied
showed
9b
bind
RET
enzyme
binding
energies
-6.8
kcal/mol
comparison
standard
alectinib,
exhibits
energy
-7.2
kcal/mol.
HSP
90
(ΔG)
-6.8
kcal/mol,
is
comparable
Onalespib
(-7.1
kcal/mol).
Journal of Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 29, 2024
This
work
introduces
a
novel
Pt(II)
based
prodrug
TTFA-Platin
that
integrates
β-diketonate
ligand
TTFA
with
platinum
scaffold
to
structurally
resemble
carboplatin
and
offers
intermediate
kinetic
lability
between
cisplatin
carboplatin,
striking
balance
therapeutic
efficacy
safety.
A
comprehensive
stability
speciation
study
was
conducted
in
various
biological
media,
mapping
the
effects
of
TTFA-Platin.
control
molecule,
TMK-Platin,
synthesized
further
validate
structural-stability
relationship,
which
displayed
poor
activatable
features
systems.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 26, 2024
Abstract
In
this
study,
new
tetrahydrosoquinoline
compounds
were
synthesized
by
reacted
with
methyl
iodide,
chloro
acetonitrile,
ethyl
chloroacetate,
N-arylchloroacetamides
N-and
(benzthiazol-2-yl)-2-chloroacetamide
reagents
to
gave
tetrahydroiso-quinolin-3-ylthio)
acetamides
(5a-c)
which
can
cyclized
(6a-c)
in
excellent
yields.
The
structures
of
all
newly
characterized
elemental
and
spectral
analyses.
Also,
most
the
evaluated
for
their
anticancer
activity
MCF7HEPG2
cell
lines.
From
result
we
found
that
potent
compound
against
lines
was
9b,
active
3.
Then
effects
3
on
HEPG2
line
investigated
using
an
apoptotic
Annexin
V-FITC
test
flow
cytometry.
Compound
induced
a
59-fold
increase
apoptosis
cycle
arrested
at
G0-G1,
G2/M
phases.
Moreover,
molecular
docking
study
applied
showed
9b
bind
RET
enzyme
binding
energies
-6.8
kcal/mol
comparison
standard
alectinib,
exhibits
energy
-7.2
kcal/mol.
HSP
90
(ΔG)
-6.8
kcal/mol,
is
comparable
Onalespib
(-7.1
kcal/mol).